Molecular Genetic and Pathological Studies of Anal Tumors

Stanford University

Status: Terminated

Conditions: Anal Cancer; Colonic Neoplasms; Colon Cancer; Rectal Cancer

Treatments: Other: genetic analysis

Study type: Observational

Funder types: Other

Identifiers

NCT00267787

95340 (Other Identifier)

ANAL0001 (Other Identifier)

14037 (Other Identifier)

Details and patient eligibility

About

Study the Genetics of Anal Cancer

Full description

To determine the status of previously identified anal cancer molecular markers and any correlations with outcome as well as to discover new molecular biomarkers through correlating molecular data with clinical outcome. Study of tissue samples and cells from biopsies of your lesion and blood sample. We hope to learn the role genes and proteins may play in the development of anal cancer. Experiments will be performed using this tissue and blood, include analysis of DNA, analysis of RNA expression levels, analysis of protein levels of important gene products, and development of tissue culture cell lines.

Enrollment: 7 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Inclusion Criteria:

• Patients with anal tumors
• Undergoing surgery for elective colon and rectal surgery Exclusion Criteria:No other patients other than adult patients with anal cancer or high risk for anal cancer refered to Stanford will be enrolled to the study. No Children will be included to the study